Get started
Merus N.V.Merus N.V.Merus N.V.

Merus N.V.

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Forecast Seasonals

A2AKFX chart


Full chart

A2AKFX upcoming earnings


Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪3.12 B‬ EUR
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−3.2025 EUR
Net income (FY)
‪−208.00 M‬ EUR
Revenue (FY)
‪34.90 M‬ EUR
Shares float
‪61.26 M‬
Beta (1Y)
0.70

Employees


Employees (FY)
260
Change (1Y)
+31 +13.54%
Revenue / Employee (1Y)
‪134.24 K‬ EUR
Net income / Employee (1Y)
‪−800.00 K‬ EUR

About Merus N.V.


Sector
Health Technology
Industry
Biotechnology
CEO
Sven Ante Lundberg
Website
merus.nl
Headquarters
Utrecht
Founded
2003
ISIN
NL0011606264
FIGI
Merus NV is a clinical-stage immuno-oncology company, which engages in the discovery and development of bispecific antibody therapeutics. Its pipeline includes Biclonics for solid and hematological tumors. The company was founded by Ton Logtenberg and Hennie Hoogenboom on June 16, 2003 and is headquartered in Utrecht, the Netherlands.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

A2AKFX news



Technicals


Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.


Frequently Asked Questions


The current price of A2AKFX is 45.4000 EUR — it has increased by 7.08% in the past 24 hours. Watch Merus N.V. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on LSX exchange Merus N.V. stocks are traded under the ticker A2AKFX.
A2AKFX stock has risen by 11.27% compared to the previous week, the month change is a 14.65% rise, over the last year Merus N.V. has showed a −5.02% decrease.
We've gathered analysts' opinions on Merus N.V. future price: according to them, A2AKFX price has a max estimate of 100.61 EUR and a min estimate of 61.84 EUR. Watch A2AKFX chart and read a more detailed Merus N.V. stock forecast: see what analysts think of Merus N.V. and suggest that you do with its stocks.
A2AKFX reached its all-time high on Nov 11, 2024 with the price of 50.5000 EUR, and its all-time low was 37.8000 EUR and was reached on Jan 13, 2025. View more price dynamics on A2AKFX chart.
See other stocks reaching their highest and lowest prices.
A2AKFX stock is 6.61% volatile and has beta coefficient of 0.70. Track Merus N.V. stock price on the chart and check out the list of the most volatile stocks — is Merus N.V. there?
Today Merus N.V. has the market capitalization of ‪3.12 B‬, it has increased by 1.62% over the last week.
Yes, you can track Merus N.V. financials in yearly and quarterly reports right on TradingView.
Merus N.V. is going to release the next earnings report on May 13, 2025. Keep track of upcoming events with our Earnings Calendar.
A2AKFX earnings for the last quarter are −0.43 EUR per share, whereas the estimation was −0.86 EUR resulting in a 49.43% surprise. The estimated earnings for the next quarter are −0.97 EUR per share. See more details about Merus N.V. earnings.
Merus N.V. revenue for the last quarter amounts to ‪8.79 M‬ EUR, despite the estimated figure of ‪10.32 M‬ EUR. In the next quarter, revenue is expected to reach ‪7.72 M‬ EUR.
A2AKFX net income for the last quarter is ‪−29.87 M‬ EUR, while the quarter before that showed ‪−89.73 M‬ EUR of net income which accounts for 66.71% change. Track more Merus N.V. financial stats to get the full picture.
No, A2AKFX doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Mar 13, 2025, the company has 260.00 employees. See our rating of the largest employees — is Merus N.V. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Merus N.V. EBITDA is ‪−260.42 M‬ EUR, and current EBITDA margin is −746.12%. See more stats in Merus N.V. financial statements.
Like other stocks, A2AKFX shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Merus N.V. stock right from TradingView charts — choose your broker and connect to your account.